Stellus Capital Investment Corporation Reports Results for its Third Fiscal Quarter Ended September 30, 2025

Stellus Capital Investment Corporation (NYSE: SCM) (“Stellus”, “we”, or the “Company”) today announced financial results for its fiscal quarter ended September 30, 2025. https://mma.prnewswire.com/media/416430/Stellus_Capital_Investment_Corporation_Logo.jpg Robert T. Ladd, Chief Executive Officer of Stellus, stated, “I am pleased to report solid operating results for the quarter ended September 30, 2025, in which we earned U.S. GAAP net […]

PIH Health Awarded 2025 CHIME Digital Health Most Wired Recognition

The College of Healthcare Information Management Executives (CHIME) has recognizedPIH Health and PIH Health Physicians as 2025 Digital Health Most Wired recipients. The Digital Health Most Wired Survey is an internationally recognized benchmarking program that honors excellence in digitally enabled healthcare. https://mma.prnewswire.com/media/1059147/PIH_Health_Logo.jpg PIH Health was awarded Certified Level 8 for Acute Care settings, recognizing all

JOHN HANCOCK CLOSED-END FUNDS RELEASE EARNINGS DATA

The John Hancock Closed-End Funds listed in the table below announced earnings1 for the three months ended October 31, 2025. The same data for the comparable three-month period ended October 31, 2024 is also available below. Three Months Ended 10/31/2025Ticker Fund Name Current Fiscal Net Investment Per Common NAV Total Managed Assets Total Net Assets

Airport Worker Union to Jacksonville City Council: End Partnership with Paradies Lagardère at Jacksonville International Airport

UNITE HERE Local 40 sent a letter on Friday to Jacksonville City Council, raising concerns about the Jacksonville Aviation Authority's (JAA) partnership with airport concessions operator Paradies Lagardère. JAA will be awarding a new Retail Concessions contract on November 17th, for which Paradies is one of the applicants. The letter outlines a series of issues

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

(NasdaqGM:OBIO),(NasdaqGM:LGND),(NYSE:MDT), Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from Terumo Initiated patient enrollments in the Virtue Trial evaluating Virtue(R) Sirolimus AngioInfusion(TM) Balloon (“Virtue SAB”) trial versus

Cruisebound Named One of PhocusWire’s “Hot 25 Travel Startups for 2026”

Cruisebound, the online cruise agency reinventing how travelers book cruises, is proud to be recognized as one of PhocusWire's “Hot 25 Travel Startups for 2026.” https://mma.prnewswire.com/media/2639657/Cruisebound_Logo.jpg “This recognition signals that our approach to making cruise booking intuitive and accessible is working,” said Pierre-Olivier Lepage, CEO at Cruisebound. “By uniting smart offers, transparent comparisons, and real

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates

Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates GlobeNewswire November 10, 2025 Secured $147.6 million in proceeds and committed capital following completion of strategic transactions and concurrent public and private equity offerings, led by $71.6 million in committed capital from Medtronic and Ligand, as well as $30 million from Terumo

Vroom Announces Third Quarter 2025 Results

Vroom Announces Third Quarter 2025 Results Continued Investment in our Long-Term Strategic Plan GlobeNewswire November 10, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — Vroom, Inc. (Nasdaq:VRM) today announced financial results for the third quarter ended September 30, 2025. HIGHLIGHTS OF THIRD QUARTER 2025 $59.2 million consolidated total available liquidity(1) as of September 30,

LAVA Therapeutics N.V. Shareholders are Reminded to Tender Shares for XOMA Royalty Transaction Before November 12, 2025 Deadline

(NASDAQ:LVTX),(NasdaqGM:XOMA), UTRECHT, The Netherlands and PHILADELPHIA, Nov. 10, 2025 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (“LAVA”) (NASDAQ: LVTX) today announced a reminder to LAVA shareholders related to the proposed transaction with XOMA Royalty Corporation (“XOMA”) (NASDAQ: XOMA). On August 4, 2025, XOMA and LAVA announced they had entered into a share purchase agreement. More recently,

Consolidated Water Reports Third Quarter 2025 Results

(NASDAQ:CWCO), GEORGE TOWN, Cayman Islands, Nov. 10, 2025 (GLOBE NEWSWIRE) — Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and treatment plants, reported results for the third quarter ended September 30, 2025. All comparisons are to the same prior year period unless otherwise noted.

Scroll to Top